The therapeutic effect of reactive oxygen species (ROS)-involved cancer therapies is significantly limited by shortage of oxy-substrates, such as hypoxia in photodynamic therapy (PDT) and insufficient hydrogen peroxide (H 2 O 2 ) in chemodynamic therapy (CDT). Here, we report a H 2 O 2 /O 2 self-supplying nanoagent, (MSNs@CaO 2 -ICG)@LA, which consists of manganese silicate (MSN)-supported calcium peroxide (CaO 2 ) and indocyanine green (ICG) with further surface modification of phase-change material lauric acid (LA). Under laser irradiation, ICG simultaneously generates singlet oxygen and emits heat to melt the LA. The exposed CaO 2 reacts with water to produce O 2 and H 2 O 2 for hypoxia-relieved ICG-mediated PDT and H 2 O 2 -supplying MSN-based CDT, acting as an open source strategy for ROS production. Additionally, the MSNs-induced glutathione depletion protects ROS from scavenging, termed reduce expenditure. This open source and reduce expenditure strategy is effective in inhibiting tumor growth both in vitro and in vivo, and significantly improves ROS generation efficiency from multi-level for ROS-involved cancer therapies. R eactive oxygen species (ROS), mainly including active superoxide anions (O 2 − ), hydroxyl radicals (•OH), and singlet oxygen ( 1 O 2 ), act as significant signaling and regulatory molecules at physiologic levels, conversely, will damage cells once the concentration elevate at an abnormal level 1 . Elevated ROS level is one of the characteristics of tumor microenvironment (TME), and along with high ROS elimination rates exist in cancer cells to maintain a steady equilibrium state, called self-adaptation mechanisms. Thus, cancer cells are more sensitive to further enhanced oxidative stress beyond the cellular tolerability threshold 2 . On this basis, ROS-mediated therapies, such as photodynamic therapy (PDT) 3-6 and chemodynamic therapy (CDT) [7] [8] [9] [10] [11] , are developed to disrupt the cellular self-adaptation mechanisms and induce cell death based on ROS-generating agents 12 .
R eactive oxygen species (ROS), mainly including active superoxide anions (O 2 − ), hydroxyl radicals (•OH), and singlet oxygen ( 1 O 2 ), act as significant signaling and regulatory molecules at physiologic levels, conversely, will damage cells once the concentration elevate at an abnormal level 1 . Elevated ROS level is one of the characteristics of tumor microenvironment (TME), and along with high ROS elimination rates exist in cancer cells to maintain a steady equilibrium state, called self-adaptation mechanisms. Thus, cancer cells are more sensitive to further enhanced oxidative stress beyond the cellular tolerability threshold 2 . On this basis, ROS-mediated therapies, such as photodynamic therapy (PDT) [3] [4] [5] [6] and chemodynamic therapy (CDT) [7] [8] [9] [10] [11] , are developed to disrupt the cellular self-adaptation mechanisms and induce cell death based on ROS-generating agents 12 .
The PDT utilities light-activated photosensitizers to convert oxygen (O 2 ) to ROS 13 , whereas CDT takes advantage of an in situ Fenton or Fenton-like reaction between hydrogen peroxide (H 2 O 2 ) and catalysts to generate cytotoxic hydroxyl radical (•OH) 14, 15 . Recently, the PDT/CDT combination therapy has been continuously explored to amplify the tumor oxidative stress and achieve better anticancer therapeutic effect than monotherapy [16] [17] [18] [19] [20] . However, the TME feature of hypoxia, depletable amount of H 2 O 2 and the glutathione (GSH) depletion effect on ROS still limit ROS efficiency 15, 21, 22 . Two different feasible strategies have been proposed to relieve hypoxia in PDT and supplement the cellular amount of H 2 O 2 in CDT, respectively, amplifying endogenous O 2 / H 2 O 2 generation 11, [23] [24] [25] [26] or directly delivering exogenous O 2 /H 2 O 2 into cells [27] [28] [29] . To date, there have indeed been some nanosystems for synergistic PDT/CDT, but most of them only overcome part of the limitations. For example, Liu et. al constructed sorafenib@Fe 3+ -tannic acid nanoparticles with GSH depletion property for PDT/ CDT 19 . Copper ferrite nanospheres 18 , copper/manganese silicate nanospheres 16 , and ROS-activatable liposomes 30 have been reported for hypoxia-relieved and GSH-depleting synergistic PDT/CDT. At present, simultaneous hypoxia relief, H 2 O 2 supplement, and GSH-depletion nanosystems have been little reported, which is highly desirable in PDT/CDT combination therapy. CaO 2, a safe solid inorganic peroxide, can decompose to simultaneously release O 2 and H 2 O 2 in contacting with water 31 and have been widely applied in remediation of environmental contamination 32 . Therefore, the introduction of CaO 2 into ROS-involved therapies seem to hold great promise for enhanced ROS generation.
Herein, a H 2 O 2 /O 2 self-supplying thermoresponsive nanosystem, (MSNs@CaO 2 -ICG)@LA, consisting of manganese silicate (MSNs) supported calcium peroxide (CaO 2 ) nanoparticles (NPs) and indocyanine green (ICG) with further surface coating of a phase-change material lauric acid (LA, melting point: 44~46°C), is reported for photodynamic/chemodynamic synergistic cancer therapy (Fig. 1) . In this nanosystem, the CaO 2 is protected from water by LA until the outer layer LA is melted owing to the photothermal effect of ICG under the irradiation of a nearinfrared (NIR) 808 nm laser. @LA can simultaneously overcome the main limitations including hypoxia, depletable amount of H 2 O 2 and GSH elimination effect on ROS for synergistic PDT/CDT, and this open source and reduce expenditure ROS-produced way obtain excellent tumor inhibition effect both in vitro and in vivo, provide a universal idea of therapeutic nanoagents design for synergistic PDT/CDT.
Results
Preparation and characterization of (MSNs@CaO 2 -ICG)@LA. The MSNs with an average diameter of 120 nm were synthesized by a hydrothermal method (Supplementary Figure 1a) . The CaO 2 NPs with an average diameter of 20 nm were prepared through a hydrolysis-precipitation process (Supplementary Figure 1b) 33, 34 . Then, the CaO 2 NPs were assembled onto the surface of MSNs to form MSNs@CaO 2 NPs in methanol through electrostatic adsorption, confirmed by the transmission electron microscope (TEM) images (Fig. 2a) and X-ray diffraction (XRD) pattern with the characteristic peaks belong to MSNs and CaO 2 , respectively (Fig. 2b) . The successful assembly of MSNs@CaO 2 was also validated by the X-ray photo-electron spectroscopy (XPS) analysis ( Supplementary Figure 2a) , and the high resolution XPS revealed that the O 2 s existed primarily in the form of silicate and peroxo groups (Supplementary Figure 2b) , and the Mn 2p 3/2 mainly consisted of 34.65% Mn 2+ (641 eV), 55.74% Mn 3+ (642 eV), and 9.61% Mn 4+ (644 eV) (Fig. 2c) 11, 16 . The high content of Mn 3+ in MSNs made it possible to react with endogenous GSH for further biodegradation 16, 35 , and the TEM analysis confirmed the gradual biodegradation of MSNs in the presence of GSH (Supplementary Figure 3) . Thus, MSNs could degrade to release Mn 2+ for CDT by depleting ROS scavenger GSH, which was beneficial to amplify the therapeutic effect 36 . ICG is a NIR tricarbocyanine dye approved by the US Food and Drug Administration for clinical use and show great potential both in PDT and PTT 37, 38 . We further incorporated ICG into the nanosystem to utilize its photothermal property and 1 O 2 generation capacity. The strong absorption peak centered at 800 nm in UV-vis spectra of MSNs@CaO 2 -ICG validated the integration of ICG molecules into the nanosystem, and the loading content of ICG was estimated to be 7.87 wt % (Fig. 2d) . The phase-change material LA with good biocompatibility and biodegradability 39, 40 was added as coating to obtain (MSNs@CaO 2 -ICG)@LA with thermo-responsive property. The TEM image of (MSNs@CaO 2 -ICG)@LA showed the uniform size (Fig. 2e ) and the change of surface zeta potential (Supplementary Figure 4) confirmed the preparation process. The differential scanning calorimetry (DSC) curves of (MSNs@CaO 2 -ICG)@LA exhibited a similar melting point to pure LA, validating the successful coating of LA on MSNs@CaO 2 -ICG (Fig. 2f) . The resulting (MSNs@CaO 2 -ICG)@LA also showed good stability in water, PBS (10 mM, pH 7.4) and Dulbecco's modified eagle medium (DMEM) solution demonstrated by the hydrodynamic particle size and surface zeta potential analysis after 24 h (Supplementary Figure 5) . (Fig. 3a) , suggesting the LA coating can protect CaO 2 from reacting with water beforehand. In addition, the H 2 O 2 releasing was increased when the pH descended, suggesting the acidic environment in tumors was good for the H 2 O 2 generation (Supplementary Figure 6) Figure 11c) . Similar results to the MB degradation experiments were also obtained by electron paramagnetic resonance (EPR) analysis of •OH production of (MSNs@CaO 2 -ICG)@LA as shown in Fig. 3d . The released Mn 2+ from MSNs could also be utilized as MRI contrast agent. As shown in Fig. 3e , the T 1 signal intensity of MSNs (group I) had negligible change and the released Mn 2+ were at very low concentration, whereas MSNs treated with 10 mM GSH (group II) exhibited enhanced brightness derived from paramagnetic Mn 2+ centers because MSN was reduced by GSH and the increasing free Mn ions (Supplementary Table 1) were easier to proceed chemical exchange with protons than isolated Mn centers in MSNs for enhanced T 1 signal 42 . Thus, it was rational that (MSNs@CaO 2 -ICG)@LA displayed enhanced brightness only when co-treated with GSH and NIR laser irradiation (group IV). Remarkably, the longitudinal relaxivity coefficient (r 1 ) of group IV and correspongding released Mn concentration were larger than that of group II (Fig. 3f) . This was attributed to the enhanced release of Mn 2+ from MSNs accelerated by photothermal effect of ICG (Supplementary Table 1 ).
Intracellular uptake of (MSNs@CaO 2 -ICG)@LA. Before evaluating the feasibility of (MSNs@CaO 2 -ICG)@LA for in vivo antitumor therapy, the cytotoxicity and cell uptake of (MSNs@ CaO 2 -ICG)@LA were first investigated. As shown in Fig. 4a , the (MSNs@CaO 2 -ICG)@LA showed little cytotoxicity toward MCF-7, A549, and NHDF cells when the concentration was from 0 to 50 μg mL −1 after incubation for 12 h, indicating good biocompatibility. The flow cytometry was conducted to measure the fluorescence intensity of ICG in MCF-7 cells treated with (MSNs@CaO 2 -ICG)@LA at different incubation time point (Fig. 4b) , and the corresponding analysis of mean fluorescence intensity was shown in Fig. 4c . Comparing with the blank control group, the cells treated with (MSNs@CaO 2 -ICG)@LA demonstrated high uptake rate as the incubation time extended, and incubation for 4 h was sufficient. Figure 4d demonstrated that the location of (MSNs@CaO 2 -ICG)@LA in MCF-7 cells overlapped with lysosome after incubation for 4 h, suggesting the endolysosomal pathway.
Intracellular enhanced ROS production. To investigate the enhanced ROS production of (MSNs@CaO 2 -ICG)@LA in living cells, we first explored the intracellular O 2 self-supplying property of CaO 2 . As shown in Supplementary Figure 12 , after hypoxia treatment, the red fluorescence intensity related to hypoxia of cells nearly remained unchanged when incubated with CaO 2 @LA, while that of CaO 2 -treated group was significantly weaken, confirming the intracellular hypoxia relief by CaO 2 . The CaO 2 -mediated O 2 selfsupply provided the possibility to enhance the ROS production and PDT efficiency. As expected, the intracellular fluorescence imaging by ROS probe (DCFH-DA, green) and hypoxia probe demonstrated that the (MSNs@CaO 2 -ICG)@LA-treated cells with irradiation displayed the strongest green fluorescence and slight enhanced red fluorescence compared with other groups both under normoxia or hypoxia conditions ( Fig. 4e and Supplementary Figure 13) , indicating tremendous ROS generation enhanced by O 2 and H 2 O 2 selfsupply from CaO 2 . In order to further investigate the enhanced CDT/PDT therapeutic effect, we used MCF-7 cancer cells as model cell to examined the anticancer effect of (MSNs@CaO 2 -ICG)@LA in normoxia as well as hypoxia environment as contrast. Upon a 808 nm laser irradiation, the (MSNs@CaO 2 -ICG)@LA treatment showed greatly enhanced cytotoxicity than both MSNs and (MSNs-ICG)@LA in normoxia environment (Fig. 4f ), in consistent with the calcein-AM and propidium iodide (PI) co-staining results that most of cancer cells were killed when treated with (MSNs@CaO 2 -ICG) @LA plus irradiation (Fig. 4g) . Notably, the hypoxia condition had obvious influence on the cell killing ability of (MSNs-ICG)@LA-treated group, whereas that of (MSNs@CaO 2 -ICG)@LA-treated group almost the same both in normoxia and in hypoxia conditions owing to the O 2 self-supplying property of CaO 2 (Fig. 4f) .
In vivo tumor treatment efficiency of (MSNs@CaO 2 -ICG)@LA. The antitumor efficacy of (MSNs@CaO 2 -ICG)@LA-mediated CDT/PDT synergistic therapy in vivo was further conducted in MCF-7 tumor-bearing mice. Figure 5a exhibited the blood circulation curve of (MSNs@CaO 2 -ICG)@LA in mice by measuring the concentrations of Mn 2+ in the blood at different time points after tail vein injection, and the fairly long circulation time was favorable for effective tumor accumulation of (MSNs@CaO 2 -ICG)@LA in tumor site due to the EPR effect which was observed in Fig. 5b . After irradiation by 808 nm laser for 10 min, the tumor-site temperature of (MSNs@CaO 2 -ICG)@LA-treated mice gradually increased to 46.8°C, which exceeded the melting point temperature of LA, whereas the control group treated with 808 nm laser-irradiation only did not display obvious temperature change in tumor site (Supplementary Figure 14) . We also investigated the MRI property of (MSNs@CaO 2 -ICG)@LA in vivo. As shown in Fig. 5c , the brightness in tumor site of mice treated with MSNs was obviously enhanced than the control group, indicating the MSNs could degrade to Mn 2+ by GSH in vivo. As for (MSNs@CaO 2 -ICG)@LA-treated mice, the T 1 signal intensity became very strong after irradiation of an 808 nm laser, confirming the thermo-responsive property of the nanosystem again. The in vivo MRI property of (MSNs@CaO 2 -ICG) @LA provided a powerful tool for guiding and monitoring therapy. Then, we divided the MCF-7 tumor-bearing nude mice into six group (n = 5) to investigate the antitumor efficacy of different treatments. The tumor volumes of all groups were recorded every 2 days and the tumors were collected at 14 days. As show in Fig. 5d and Supplementary Figure 15 , relatively stable body weight and histopathological normal hematoxylin and eosin (H&E) staining of main organs in all groups suggested the negligible side effects of these treatments on mice. The 808 nm laser irradiation alone displayed little inhibition effect on tumor growth similar to the control group (Fig. 5e, f) . The MSNs and showed some tumor repression effects owing to the CDT therapeutic efficacy. The tumors were significantly suppressed in the group of (MSNs-ICG)@LA and an 808 nm laser due to the therapeutic effect of CDT/PDT, and the tumors in the group treated with (MSNs@CaO 2 -ICG)@LA and an 808 nm laser irradiation were completely eliminated owing to the strongest ROS generation in H 2 O 2 /O 2 self-supplying CDT/PDT (Fig. 5g and  Supplementary Figure 16) . The corresponding H&E and TUNEL staining of tumor slides also displayed the maximum tumor necrosis and apoptosis (Fig. 5h) . These results indicated that (MSNs@CaO 2 -ICG)@LA have excellent antitumor effects due to combined PDT/CDT with H 2 O 2 and O 2 self-supply.
Discussion
In summary, we rationally designed a thermo-responsive nanosystem through simple assembly method for overcoming the insufficient supply of O 2 and H 2 O 2 in antitumor PDT and CDT. The (MSNs@CaO 2 -ICG)@LA nanosystem was constructed by decorating CaO 2 and ICG on the MSN-support with further surface modification of phase-change material LA. We demonstrated that phase-change material LA could be melted owing to the photothermal effect of excited ICG under irradiation, and then CaO 2 could be exposed to react with water to release O 2 and H 2 O 2 to enhance the ROS generation in ICG-mediated PDT and Mn 2+ -involved CDT, respectively, acting as an open source strategy for ROS production. The Fenton-like agent Mn 2+ released out from MSNs depleted ROS scavenger GSH, which further reduced ROS wastage termed reduce expenditure. Our results showed excellent tumor eradication effect of (MSNs@CaO 2 -ICG)@LA owing to the combined PDT/CDT with O 2 /H 2 O 2 self-supply and GSH depletion. This work demonstrated a promising open source and reduce expenditure strategy for ROS generation enhancement in ROSinvolved cancer therapies.
Methods
Instruments. The morphologies of samples were characterized by TEM (HT7700, Hitachi, Japan). XRD was conducted by a Bruker D8 ADVANCE X. DSC measurements were conducted by DSC Q2000 (TA Instruments, USA) under nitrogen atmosphere. Dissolved oxygen measurement was conducted by JPBJ-608 (Rex, INESA Scientific Instrument). The cell fluorescence imaging was obtained by confocal laser scanning fluorescence microscope (CLSM, FV1200, Olympus, Japan). In vitro and in vivo MRI was performed by an animal MRI scanner (BioSpec70/20USR, Bruker, Germany) at 7.0 T with a gradient echo sequence (TR = 299 ms and TE = 6.01 ms).
Synthesis of manganese silicate nanoparticles (MSNs).
The previously reported dendritic mesoporous silica nanoparticles 33 were used as self-killing templates to synthesize MSNs. First, dendritic mesoporous silica nanoparticles (50 mg), MnCl 2 ·4H 2 O (158.34 mg) and NH 4 Cl (534.9 mg) were dispersed in 40 mL of water. Then NH 3 ·H 2 O (28% wt., 1 mL) was added dropwise into the mixture under continuously stirring. After stirring for 30 min, the mixture was transferred into a Teflon-lined autoclave and maintained at 180°C for 24 h. The precipitates were washed with water and finally dried at 60°C.
PEGylation of MSNs. In brief, MSNs (1 mg) were mixed with methoxy PEG silane (Mw = 2000, 5 mg) in 10 mL of ethanol under magnetic stirring at 60°C for 24 h. Then, the MSNs-PEG were washed with ethanol and ultrapure water several times.
Synthesis of (MSNs@CaO 2 -ICG)@LA. The CaO 2 nanoparticles were synthesized according to previous literature 34 . In brief, ultrapure water (3 mL), calcium chloride (2.7 mmol), ammonia solution (1.5 mL, 1 M) and PEG400 (12 mL) were successively added in the round bottom flask under stirring. Then H 2 O 2 (35 wt. %, 1.5 mL) was dropwise added to the mixture within 50 min. After further stirring for 2 h at 900 rpm at room temperature, the pH of mixture was adjusted to 11.5 using NaOH solution (0.1 M). The precipitate was washed three times with NaOH (0.1 M) and with distilled water until the pH of supernatant reached to 8.4. The precipitate was dried in vacuo at 80°C for 2 h, then resuspended in ethanol and filtered using a Millex Filter Unit (0.45 μm). The resulting filtrate was concentrated and dried to achieve CaO 2 nanoparticles. MSNs (1 mg) and CaO 2 (1 mg) were mixed in methanol (5 mL) and stirred for 12 h. Then, ICG (1 mg) was added to the mixture under stirring. After 2 h, lauric acid (0.1 g) was added and the mixture was stirred for another 5 h. The precipitates were washed with methanol for three times. The as-obtained composites were denoted as (MSNs@CaO 2 -ICG)@LA. The loading capacity of ICG was determined by dissolving the (MSNs@CaO 2 -ICG)@LA in methanol, and the characteristic absorption at 788 nm was measured by UV-1800 spectrophotometer (Shimadzu, Japan). Extracellular measurement of NIR-triggered ICG release. The aqueous solution of (MSNs@CaO 2 -ICG)@LA (200 μg mL −1 , 1 mL) was irradiated by laser (808 nm, 0.64 W cm −2 ) with different time (0, 2, 4, 6, and 8 min) or was not exposed to the NIR laser. Then, the sample solution was centrifuged. The released ICG in supernatant solution was characterized by measuring the absorption of ICG at 788 nm.
In vitro MRI imaging property. In all, 100 μL MSNs or (MSNs@CaO 2 -ICG)@LA ([Mn]: 5 mM) was added into 900 μL PBS solution (10 mM, pH = 7.4) containing 25 mM NaHCO 3 /5% CO 2 without or with GSH (10 mM). After shaken at 37°C for 1 h, MRI images and the T 1 relaxation time of diluted supernatant (Mn concentration: 0, 0.1, 0.2, 0.4, and 0.5 mM) were measured by MRI system. Cell cytotoxicity. The human MCF-7 breast cancer cells, human A549 adenocarcinoma alveolar basal epithelial cells and NHDF normal human dermal fibroblasts cells were purchased from Cell Bank, the Committee of Type Culture Collection of Chinese Academy of Sciences. NHDF, MCF-7, and A549 cells were seeded in 96-well plates (10 4 cells per well) respectively and incubated in DMEM medium containing 10% FBS and 1% antibiotics (penicillin−streptomycin, 10,000 U mL −1 ) at 37°C under 5% CO 2 for 12 h. Then the cells were incubated with OPTI-MEM solution containing (MSNs@CaO 2 -ICG)@LA at desired concentrations for 4 h, washed with PBS (10 mM, pH = 7.4) for three times and further incubated with DMEM medium for another 24 h. Finally, culture medium containing 10% of CCK-8 was added to each well. After incubation at 37°C for 1 h, the absorbance at 450 nm of each well was obtained by microplate reader. In vivo blood circulation and biodistribution. MCF-7 cancer-bearing female mice were intravenously injected with (MSNs@CaO 2 -ICG)@LA (10 mg kg −1 ). At indicated time points (0.1, 0.5, 1, 2, 4, 6, 11, 24 h), we collected 50 μL blood from the tail of each mouse. After intravenous injection for 24 h, the mice were killed to measure the Mn amount in liver, spleen, kidney, heart, lung, tumor as well as blood samples by ICP-OES.
In vivo MRI imaging. The in vivo MRI imaging experiments were conducted on MCF-7 tumor-bearing female mice when the tumor volume reached about 100 mm 3 Statistical analysis. Data were calculated and processed as mean ± SD. Comparison analysis between groups was conducted by student's t test (two tailed).
Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
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